In the clinical trial of SK elimination using the novel, non-thermal NPS technology, seborrheic keratosis lesion reduction assessments of a single, localized SK treatment showed that 82% of 174 ...
"These publications represent important progress in our understanding of cenobamate's clinical profile," said Sunita N. Misra, MD, PhD, Senior Vice President, Clinical Development and Medical Affairs, ...
(RTTNews) - SK bioscience announced positive results from its Phase II clinical trials in infants of its 21-valent pneumococcal conjugate vaccine candidate, 'GBP410' also known as SP0202, evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results